Business
NexGelRx Receives Additional Investment from Eric Gruntfest of Diesis Holdings, LLC and Appoints Him as Board Observer and Strategic Advisor
LANGHORNE, Pa., Dec. 16, 2025 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced that NexGelRx, the Company’s previously announced spin-off of select drug delivery application assets, has received strategic investments from Eric Gruntfest and Ariel Imas of Diesis Holdings, L
About this update from Nexgel, Inc
[{"type":"image","alt":"NEXGEL, INC.","displaySize":"","headline":null,"caption":"NEXGEL, INC.","className":"","disableSlideshowImg":false,"size":{"original":{"width":250,"height":66,"url":"https://media.zenfs.com/en/globenewswire.com/7f0d3c847df57a7d87b54e7056dbb4aa"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/ONAbP5tUr9hDfjARTjK8NA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTExMTtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/7f0d3c847df57a7d87b54e7056dbb4aa","width":250,"height":66}},"lazy":false},{"type":"text","content":"LANGHORNE, Pa., Dec. 16, 2025 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced that NexGelRx, the Company’s previously announced spin-off of select drug delivery application assets, has received strategic investments from Eric Gruntfest and Ariel Imas of Diesis Holdings, LLC. In connection with the investment, NexGelRx has appointed Mr. Gruntfest to serve as a board observer and advisor, bringing deep experience in reimbursement strategy, patient access, and healthcare-commercialization leadership.","length":730,"tagName":"p"},{"type":"text","content":"Mr. Gruntfest is a seasoned healthcare executive with over 20 years of experience spanning reimbursement management, payer solutions, and patient support programs. He currently serves as Managing Partner for Diesis Holdings, LLC, and as Chief Executive Officer of RMBB Health, where he has strengthened market positioning and advanced patient access initiatives. His background includes senior leadership roles at Medtronic, MiMedx, Shire, and Celgene, with a strong record of building and leading high-performing teams across the healthcare ecosystem.","length":552,"tagName":"p"},{"type":"text","content":"“We welcome Eric as both an investor and strategic advisor to NexGelRx,” said Richard Myers, CEO of NexGelRx. “His insight will bring an important new perspective to our company and add to the depth of our stakeholder base. We have a unique, ultra-gentle hydrogel product, and we look forward to demonstrating its potential as an ideal, innovative transdermal delivery mechanism for a wide array of pharmaceuticals.”","length":416,"tagName":"p"},{"type":"text","...